Day One Biopharmaceuticals, Inc.

DAWN · Nasdaq · SIC 2834: Pharmaceutical Preparations
95
SEC Filings

Business Summary

PART I . Overview Day One Biopharmaceuticals, Inc., or the Company or Day One, is a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases. At Day One, we aim to identify and develop breakthrough medicines with the goal of improving the outcomes and life trajectories of patients of any age facing serious diseases starting from Day One. Our search & development strategy enables us to find, acquire, and develop...

Next Earnings

Q2 FY2026 — expected 2026-08-22

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionDAWNdiscussed_in_filing Cybersecurity
topic_mentionDAWNdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-242025-12-310001193125-26-066956EDGAR120K words
2025-02-252024-12-310000950170-25-026654EDGAR—
2024-02-262023-12-310000950170-24-020212EDGAR—
2023-03-062022-12-310000950170-23-006269EDGAR—
2022-03-072021-12-310000950170-22-002959EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-042025-09-300001193125-25-264649EDGAR82K words
2025-08-052025-06-300000950170-25-103012EDGAR—
2025-05-062025-03-310000950170-25-064436EDGAR—
2024-10-302024-09-300000950170-24-118958EDGAR—
2024-08-022024-06-300000950170-24-089945EDGAR—
2024-05-062024-03-310000950170-24-053612EDGAR—
2023-11-062023-09-300000950170-23-059485EDGAR—
2023-08-072023-06-300000950170-23-039118EDGAR—
2023-05-012023-03-310000950170-23-016046EDGAR—
2022-11-072022-09-300000950170-22-022667EDGAR—
2022-08-042022-06-300000950170-22-014859EDGAR—
2022-05-122022-03-310000950170-22-009734EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-060001193125-26-095174EDGAR53K words
2026-03-020001193125-26-084267EDGAR—
2026-02-240001193125-26-066926EDGAR—
2026-01-120001193125-26-009834EDGAR—
2026-01-060001104659-26-001127EDGAR—
2025-11-240001193125-25-292096EDGAR—
2025-11-130001104659-25-110812EDGAR—
2025-11-040001193125-25-264608EDGAR—
2025-10-100001193125-25-237072EDGAR—
2025-08-050000950170-25-102969EDGAR—

95 total filings indexed. 68 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001845337
TickerDAWN
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 1bb74368d3a76fe5dc2c77cdedb7c14c9297cca0b5cb9c8483de8fa644ff122a
parent: 1098641e4a11b3718910de69d34284c80d74b972824a4e4629bc9fb8dd1ad534
content hash: 084ce4039e44f7345bab19d247e4fe8d5fb2e1d6179336c666a19b063dd9fc58
signed: 2026-04-13T04:44:36.760Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf